https://medicine.ouhsc.edu/Academic-Departments Parent Page: Academic Departments id: 23201 Active Page: Faculty and Staffid:23396

Faculty and Staff

Mary Z. Baker, MD
Internal Medicine

Mary Zoe Baker, MD

David Ross Boyd Professor of Medicine
Interim Section Chief and Fellowship Director
Endocrinology, Diabetes and Metabolism Section
Paul H. and Doris Eaton Travis Chair in Endocrinology
Edith Gaylord Kinney Presidential Professor


1000 N. Lincoln Blvd., HHDC 2900
Oklahoma City, OK 73104-3252

(405) 271-5896

Mary-Baker@ouhsc.edu


Academic Section(s):

Endocrinology and Diabetes


Education:

  • 1982     Doctor of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK
  • 1977     Master of Science, Oklahoma State University, Stillwater, OK
  • ​1977     Research Fellow, Radiation Biochemistry, Lab FRAE, Bologna, Italy
  • 1973     Bachelor of Arts, Oklahoma State University, Stillwater, OK


Residency:

  • 1983 - 1985     Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK

  • 1982 - 1983     Intern, Internal Medicine, Department of Medicine, University of Oklahoma Health Science Center, Oklahoma City, OK


Fellowship:

  • 1985 - 1987     Endocrinology, Diabetes and Metabolism, University of Oklahoma Health Science Center, Oklahoma City, OK


Clinical/Research Interests:

  • Diabetes
  • Osteoporosis
  • Pituitary disease
  • Thyroid disease


Select Publications:

Smith, B. J., Leyva, M. J., Stephens, L. D., Aston, C. E., Hermann, J., Payton, M., Baker, M. Z. (2018). Relationship of American Indian blood quantum with osteoporosis risk: a cross-sectional study of American Indian women in Oklahoma. Osteoporosis international: a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 29(10), 2251-2260. PMID: 29943190. DOI: 10.1007/s00198-018-4594-6

Jenkins, A., Zhang, S. X., Gosmanova, A. K., Aston, C. E., Dashti, A., Baker, M. Z., Lyons, T., Ma, J.-X. (2008). Increased serum pigment epithelium derived factor levels in Type 2 diabetes patients. Diabetes research and clinical practice, 82(1), e5-7. PMID: 18715664. DOI: 10.1016/j.diabres.2008.06.019

Jenkins, A. J., Gosmanova, A. K., Lyons, T. J., May, K. D., Dashti, A., Baker, M. Z., Olansky, L., Aston, C. E., Dale, G. L. (2008). Coated-platelet levels in patients with Type 1 and with Type 2 diabetes mellitus. Diabetes research and clinical practice, 81(2), e8-10. PMID: 18508150. DOI: 10.1016/j.diabres.2008.04.004

Hamlett S, and Baker MZ. Primary Hyperparathyroidism and Anemia. EndoTrends 16:3, 2009.

Hasan, M.K., Tierney, W.M. and Baker, MZ Severe Cholestatic Jaundice in Hyperthyroidism after Treatment with 131-Iodine. Am J Med Sci 2004; 328(6):1-3.

Howell P, Kariampuzha S, Kipgen W, Baker, MZ, Williams GR, Title T, Scofield RH. Non-surgical therapy of primary hyperparathyroidism: experience at a low volume institution. J Okla State Med Assoc, 94:561-565, 2001.

Downs, R.W., Bone, H.G., Mellwain, H., Baker, MZ, Yates, A.J., Lombardi, A., Krupa, D., Harning, R. An Open-label Extension Study of Alendronate Treatment in Elderly Women with Osteoporosis. Calcif Tissue Int 1999; 64(6):463-9.

Perry, 3rd, H. M., Bernard, M., Horowitz, M., Miller, D. K., Fleming, S., Baker, M. Z., Flaherty, J., Purushothaman, R., Hajjar, R., Kaiser, F. E., Patrick, P., Morley, J. E. (1998). The effect of aging on bone mineral metabolism and bone mass in Native American women. Journal of the American Geriatrics Society, 46(11), 1418-22. PMID: 9809765

Baker, MZ, Scofield, RH. Educational needs of internal medicine residency graduates: general internists versus subspecialists. Med Education 32:527-532, 1998.

Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, Jr, R. W., Dequeker, J., Favus, M., Alendronate Phase III Osteoporosis Treatment Study Group (1995). Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. The New England journal of medicine, 333(22), 1437-43. PMID: 7477143. DOI: 10.1056/NEJM199511303332201

Schiebinger, R. J., Baker, M. Z., Linden, J. (1987). Effect of adrenergic and muscarinic cholinergic agonists on atrial natriuretic peptide secretion by isolated rat atria. Potential role of the autonomic nervous system in modulating atrial natriuretic peptide secretion. The Journal of clinical investigation, 80(6), 1687-91. PMID: 2890660. DOI: 10.1172/JCI113258

Baker, M. Z., Badiello, R., Tamba, M., Quintiliani, M., Gorin, G. (1982). Pulse radiolytic study of hydrogen transfer from glutathione to organic radicals. International journal of radiation biology and related studies in physics, chemistry, and medicine, 41(6), 595-602. PMID: 6981616.